apolipoprotein E2 (Kyoto)

a variant of apolipoprotein E2 isoform; in which arginine at position 25 is replaced by cysteine (Arg25-Cys)

Also Known As:

apo E2 (Arg25Cys) Kyoto; apoE-Kyoto; apoE2 (Kyoto); apolipoprotein E-Kyoto

Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

1.	Lipoprotein Glomerulopathy 02/23/2022 - "The location of the gene mutation is close to the most common mutation type of lipoprotein glomerulopathy, ApoE Kyoto (Arg25Cys), so we speculate that its pathogenic role might be the similar to that of ApoE Kyoto (Arg25Cys)." 01/01/2021 - "Conclusion: APOE Kyoto is the most common mutation in patients with lipoprotein glomerulopathy. " 11/01/2016 - "Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation." 02/01/2014 - "Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation." 09/01/2012 - "We report on a 12-year-old female patient with lipoprotein glomerulopathy (LPG) who was proven to be heterozygous for ApoE2 Kyoto (Arg25Cys). "
2.	Kidney Diseases (Kidney Disease) 01/01/2021 - "Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). "